As of today (2025-06-26), NeoGenomics's share price is $7.18. NeoGenomics's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $0.27. Hence, NeoGenomics's Price to Tangible Book Ratio of today is 26.99.
The historical rank and industry rank for NeoGenomics's Price-to-Tangible-Book or its related term are showing as below:
NEO'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.07 Med: 17.5 Max: 55.74
Current: 26.59
During the past 13 years, NeoGenomics's highest Price to Tangible Book Ratio was 55.74. The lowest was 6.07. And the median was 17.50.
NEO's Price-to-Tangible-Book is ranked worse than 93.33% of 165
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.74
vs NEO: 26.59
NeoGenomics Price-to-Tangible-Book Historical Data
The historical data trend for NeoGenomics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NeoGenomics's Price-to-Tangible-Book
For the Diagnostics & Research subindustry, NeoGenomics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeoGenomics's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where NeoGenomics's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
NeoGenomics Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of NeoGenomics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEO has been successfully added to your 